0001225208-20-004028.txt : 20200303
0001225208-20-004028.hdr.sgml : 20200303
20200303125507
ACCESSION NUMBER: 0001225208-20-004028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200228
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YOUNG JOHN D
CENTRAL INDEX KEY: 0001551792
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 20680978
MAIL ADDRESS:
STREET 1: C/O CORPORATE SECRETARY
STREET 2: 235 EAST 42ND ST.
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2020-02-28
0000078003
PFIZER INC
PFE
0001551792
YOUNG JOHN D
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Group President
Common Stock
2020-02-28
4
M
0
100548.0000
27.3700
A
504427.0000
D
Common Stock
2020-02-28
4
F
0
23802.0000
33.4200
D
480625.0000
D
Common Stock
2020-02-28
4
F
0
51943.0000
36.4500
D
428682.0000
D
Common Stock
2170.0000
I
By Rule 16b-3 Plan
Common Stock
1522.0000
I
By Trustee under the Pfizer Share Ownership Plan
Stock Appreciation Rights
27.3700
2020-02-28
4
M
0
100548.0000
0.0000
D
2020-02-28
2020-02-28
Common Stock
100548.0000
0.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Susan E. Grant, by power of atty., for John D. Young
2020-03-03